Calcipotriol/Betamethasone dipropionate (Enstilar ®)

Assessment Status Rapid review complete
HTA ID -
Drug Calcipotriol/Betamethasone dipropionate
Brand Enstilar®
Indication For the topical treatment of psoriasis vulgaris in adults
Assessment Process
Rapid review commissioned 17/05/2016
Rapid review completed 21/06/2016
Rapid review outcome Full Pharmacoeconomic Evaluation Not Recommended